Octant is engineering a new generation of drug discovery.

Octant is developing a multiplexed technology that uses synthetic biology, genome engineering, next-generation sequencing, and computational tools to simultaneously measure the activity of thousands of receptor pathways in human cells, paving the way for a new modality for drug discovery.

• Industry

  • Biotechnology

• Milestones

  • Lux investment: 2017

• Founders

  • Sri Kosuri
  • Ramsey Homsany

  LUX Partners

  • Adam Goulburn

• Latest Tweets

  • Thrilled to be working with @CatalioCapital! https://t.co/mJqFvM7yo7@OctantBio - 11:49 PM May 3rd
  • Last week, we announced a few company milestones, including the hiring of our Chief Scientific Officer, Rick Artis.… https://t.co/bYRgJa8YYC@OctantBio - 04:00 PM Apr 27th
  • We’ve been hard at work building Octant. With today’s announcements, we’re another step toward executing on our mis… https://t.co/IEKQn5S7vt@OctantBio - 04:35 PM Apr 21st